Gour Medical History
Focus on medical cannabis for companion animals
Transfer of the corporate headquarter to France
GOUR Medical, animal health specialist, lists on the Marché Libre Euronext Paris
Gour Medical SA signs an exclusive manufacturing, distribution and marketing agreement with the UK company Medicom Healthcare Limited for the marketing of high-quality ophthalmic products for pets.
Gour Medical SA signs an exclusive licensing agreement with world leader in animal health diagnostics: Idexx Laboratories Inc. (NASDAQ: IDXX) for the development of an anti-IgE monoclonal antibody to treat atopic dermatitis in dogs.
Gour Medical SA signs an exclusive worldwide license, manufacturing, distribution and service agreement with the German company Solmic Research GmbH, specializing in innovative systems for the development of products based on natural cannabinoids.
Gour Medical SA signs an exclusive worldwide licensing agreement with the Swiss pharmaceutical company Actelion (SIX : ATLN) for Gour-713, an Orexine receptor antagonist to treat stress and anxiety in pets.